Product Description
The global surgical display and PACS monitor market was valued at $736.1 million in 2025. This is expected to increase over the forecast period at a CAGR of 13.3% to reach $1.86 billion.
The full report suite on the global market for surgical display and picture archiving and communication system (PACS) monitors includes HD, 4K and 8-megapixel ultra-high-definition (UHD) surgical displays and PACS monitors.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Surgical Display and PACS Monitor Market Market Trends
Aside from continued demand for 4K-compatible surgical displays, facilities are also increasing adoption of larger-format displays as operating rooms become more integrated. While a growing share of hospitals has transitioned from HD to 4K, a sizable global HD installed base remains, and the ongoing replacement of these systems is expected to drive both ASP growth and unit sales over the forecast period. In parallel, integrated OR environments are driving demand for larger surgical displays, typically ranging from 32” to 60”, which are mounted on walls or booms to improve visibility for the broader surgical team. Displays that were historically concentrated in the 21” to 24” range are increasingly being replaced by larger sizes such as 26” and 27”, alongside a growing preference for medical-grade displays throughout the OR despite higher costs compared to non-medical alternatives.
Global Surgical Display and PACS Monitor Market Market Share Insights
- Stryker was the leading competitor in the global surgical display and PACS monitor market in 2025. Stryker distributes Barco’s products. Barco’s portfolio includes a line of surgical displays suitable for use in endoscopy rooms, interventional suites or hybrid ORs, available in both HD or 4K definition. Stryker is a leading competitor in the video endoscopy market and is active in various other segments of the OR equipment market.
- KARL STORZ was the second-leading competitor in the surgical display and PACS monitor market in 2025. KARL STORZ was also the leading competitor in the integrated OR component market, a position it leveraged in order to sell its surgical displays. The company sells displays primarily from NDS Surgical Imaging (NDSsi). NDSsi focuses on visualization technology for endoscopy and offers the Radiance® Ultra line of both 4K and HD surgical displays. The company’s portfolio includes the EndoVue® family of endoscopy displays at value price, compatible with both analog and digital signals.
- Olympus was the third-leading competitor in the surgical display and PACS monitor market in 2025. The company is a leading competitor in the video endoscopy market and is active in a number of other medical device markets. Olympus distributes displays from Sony and EIZO. Sony offers the LMD surgical monitors product line with up to 4K resolution. EIZO’s broad portfolio covers surgical monitors and PACS displays, including RadiForce® line of color monitors, as well as monochrome monitors, touch panel monitors and other imaging solution for OR.
Global Surgical Display and PACS Monitor Market Market Segmentation Summary
- HD Surgical Display Market – Further Segmented Into:
- Quality: HD Display ≤27” and HD Display ≥31”.
- 4K Surgical Display Market – Further Segmented Into:
- Quality: 4K Display ≤32” and 4K Display ≥55”.
- 8-Megapixel UHD Display Market
- PACS Monitor Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
